All patients underwent liver biopsy for AIH diagnosis confirmation according to guidelines [4], which allowed the exclusion of patients with overlapping syndromes but the inclusion of five patients who were ANA negative at presentation. This evidence concerns the gene BTG3 and autoimmune hepatitis.